893 related articles for article (PubMed ID: 17161561)
21. European pharmacovigilance: increasingly outsourced to drug companies.
Prescrire Int; 2014 Dec; 23(155):302-3, 305-7. PubMed ID: 25629153
[TBL] [Abstract][Full Text] [Related]
22. European regulatory guidelines for biosimilars.
Wiecek A; Mikhail A
Nephrol Dial Transplant; 2006 Oct; 21 Suppl 5():v17-20. PubMed ID: 16959790
[TBL] [Abstract][Full Text] [Related]
23. [Illicit drugs, medications and traffic accidents].
Goullé JP; Verstraete A; Boulu R; Costentin J; Foucher JP; Raes E; Tillement JP
Ann Pharm Fr; 2008 Aug; 66(4):196-205. PubMed ID: 18847565
[TBL] [Abstract][Full Text] [Related]
24. Transparency of EU medicines agencies.
Kopp C
Prescrire Int; 2003 Aug; 12(66):156. PubMed ID: 12908499
[No Abstract] [Full Text] [Related]
25. Veterinary pharmacovigilance in the European context.
Keck G
Ann Ist Super Sanita; 1992; 28(4):425-8. PubMed ID: 1303032
[TBL] [Abstract][Full Text] [Related]
26. Harmonization of Pharmacovigilance Regulation in Brazil: Opportunities to Improve Risk Communication.
Varallo FR; Forgerini M; Herdeiro MT; de Carvalho Mastroianni P
Clin Ther; 2019 Mar; 41(3):598-603. PubMed ID: 30792075
[TBL] [Abstract][Full Text] [Related]
27. Regulatory structures for gene therapy medicinal products in the European Union.
Klug B; Celis P; Carr M; Reinhardt J
Methods Enzymol; 2012; 507():337-54. PubMed ID: 22365782
[TBL] [Abstract][Full Text] [Related]
28. [European Agency for the Evaluation of Medicinal Products: five years experience].
Sauer F
Bull Mem Acad R Med Belg; 2000; 155(5-6):254-8; discussion 259-62. PubMed ID: 11304960
[TBL] [Abstract][Full Text] [Related]
29. Implications of the accession of the Republic of Croatia to the European Union for Croatian health care system.
Ostojić R; Bilas V; Franc S
Coll Antropol; 2012 Sep; 36(3):717-27. PubMed ID: 23213925
[TBL] [Abstract][Full Text] [Related]
30. [The European Union and drugs].
Viala G; Campion MD
Ann Pharm Fr; 1995; 53(4):184-7. PubMed ID: 7574273
[TBL] [Abstract][Full Text] [Related]
31. Medicinal products in the European Union--between harmonization and divergence.
Lojko N
Med Law; 2010 Mar; 29(1):61-76. PubMed ID: 22457998
[TBL] [Abstract][Full Text] [Related]
32. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?
Trifirò G; Pariente A; Coloma PM; Kors JA; Polimeni G; Miremont-Salamé G; Catania MA; Salvo F; David A; Moore N; Caputi AP; Sturkenboom M; Molokhia M; Hippisley-Cox J; Acedo CD; van der Lei J; Fourrier-Reglat A;
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1176-84. PubMed ID: 19757412
[TBL] [Abstract][Full Text] [Related]
33. European survey on decontamination in mass casualty incidents.
Domres BD; Rashid A; Grundgeiger J; Gromer S; Kees T; Hecker N; Peter H
Am J Disaster Med; 2009; 4(3):147-52. PubMed ID: 19739457
[TBL] [Abstract][Full Text] [Related]
34. The European Medicines Agency: an overview of its mission, responsibilities, and recent initiatives in cancer drug regulation.
Pignatti F; Gravanis I; Herold R; Vamvakas S; Jonsson B; Marty M
Clin Cancer Res; 2011 Aug; 17(16):5220-5. PubMed ID: 21844037
[TBL] [Abstract][Full Text] [Related]
35. The accession countries benefit in the field of plant protection products.
Stanek A
Toxicol Lett; 2004 Apr; 149(1-3):429-32. PubMed ID: 15093291
[TBL] [Abstract][Full Text] [Related]
36. Drug development for children: how is pharma tackling an unmet need?
Hawcutt DB; Smyth RL
IDrugs; 2008 Jul; 11(7):502-7. PubMed ID: 18600597
[TBL] [Abstract][Full Text] [Related]
37. Pharmacovigilance of veterinary medicines.
Jones P; Sundlof SF
J Vet Pharmacol Ther; 2005 Apr; 28(2):127-8. PubMed ID: 15842302
[No Abstract] [Full Text] [Related]
38. Developing a European framework for research on children's medicines: an examination of the proposed EU regulation on medicinal products for paediatric use.
Seyberth HW; Demotes-Mainard J; Wrobel P
Pediatr Nephrol; 2005 Nov; 20(11):1537-40. PubMed ID: 16167134
[No Abstract] [Full Text] [Related]
39. Assessment of user safety, exposure and risk to veterinary medicinal products in the European Union.
Woodward KN
Regul Toxicol Pharmacol; 2008 Feb; 50(1):114-28. PubMed ID: 18060673
[TBL] [Abstract][Full Text] [Related]
40. New European commission regulation on variations to the terms of marketing authorization for medicinal products and its impact on Croatian legislation.
Martinac AI; Tomić S; Simicić M
Arh Hig Rada Toksikol; 2010 Sep; 61(3):311-22. PubMed ID: 20860972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
